Literature DB >> 7939166

The pharmacokinetics and electrocardiographic effects of chloroquine in healthy subjects.

M D Bustos1, F Gay, B Diquet, P Thomare, D Warot.   

Abstract

Chloroquine prophylaxis was administered to 3 healthy male volunteers at 100 mg base/day for 25 days, followed by the curative dose at 25 mg base/kg for 3 days. Subjects attained effective chloroquine (mean = 50 micrograms/l) and desethylchloroquine (mean = 17 micrograms/l) concentrations by the 3rd week of prophylaxis, underlining the need to start chloroquine prophylaxis two weeks before travel. On the second day of the treatment period, hourly electrocardiographic monitoring showed a diminution of the T wave and prolongation of the QTc interval, manifesting cumulatively during the 3 days' curative dose, but with no cardiac symptoms. A dose-dependent cumulative effect of chloroquine was demonstrated with higher blood concentrations during the treatment period. Electrocardiographic readings spontaneously normalized after the treatment period as drug concentrations diminished progressively.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7939166

Source DB:  PubMed          Journal:  Trop Med Parasitol        ISSN: 0177-2392


  18 in total

1.  In vitro cardiovascular effects of dihydroartemisin-piperaquine combination compared with other antimalarials.

Authors:  Franco Borsini; William Crumb; Silvia Pace; David Ubben; Barb Wible; Gan-Xin Yan; Christian Funck-Brentano
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

Review 2.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

3.  Chloroquine blocks a mutant Kir2.1 channel responsible for short QT syndrome and normalizes repolarization properties in silico.

Authors:  Angelica Lopez-Izquierdo; Daniela Ponce-Balbuena; Tania Ferrer; Frank B Sachse; Martin Tristani-Firouzi; Jose A Sanchez-Chapula
Journal:  Cell Physiol Biochem       Date:  2009-08-03

4.  The molecular basis of chloroquine block of the inward rectifier Kir2.1 channel.

Authors:  Aldo A Rodríguez-Menchaca; Ricardo A Navarro-Polanco; Tania Ferrer-Villada; Jason Rupp; Frank B Sachse; Martin Tristani-Firouzi; José A Sánchez-Chapula
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-23       Impact factor: 11.205

5.  Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a tolerability, safety, and preliminary efficacy study.

Authors:  John Benjamin; Brioni Moore; Sook Ting Lee; Michèle Senn; Susan Griffin; Dulci Lautu; Sam Salman; Peter Siba; Ivo Mueller; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2012-02-13       Impact factor: 5.191

6.  Phase I randomized dose-ascending placebo-controlled trials of ferroquine--a candidate anti-malarial drug--in adults with asymptomatic Plasmodium falciparum infection.

Authors:  Ghyslain Mombo-Ngoma; Christian Supan; Matthias P Dal-Bianco; Michel A Missinou; Pierre-Blaise Matsiegui; Carmen L Ospina Salazar; Saadou Issifou; Daniel Ter-Minassian; Michael Ramharter; Maryvonne Kombila; Peter G Kremsner; Bertrand Lell
Journal:  Malar J       Date:  2011-03-01       Impact factor: 2.979

7.  Randomized dose-ranging controlled trial of AQ-13, a candidate antimalarial, and chloroquine in healthy volunteers.

Authors:  Fawaz Mzayek; Haiyan Deng; Frances J Mather; Elizabeth C Wasilevich; Huayin Liu; Christiane M Hadi; David H Chansolme; Holly A Murphy; Bekir H Melek; Alan N Tenaglia; David M Mushatt; Albert W Dreisbach; Juan J L Lertora; Donald J Krogstad
Journal:  PLoS Clin Trials       Date:  2007-01-05

8.  Erythrocyte G protein as a novel target for malarial chemotherapy.

Authors:  Sean C Murphy; Travis Harrison; Heidi E Hamm; Jon W Lomasney; Narla Mohandas; Kasturi Haldar
Journal:  PLoS Med       Date:  2006-12       Impact factor: 11.069

9.  Electrocardiographic study in Ghanaian children with uncomplicated malaria, treated with artesunate-amodiaquine or artemether-lumefantrine.

Authors:  George O Adjei; Collins Oduro-Boatey; Onike P Rodrigues; Lotte C Hoegberg; Michael Alifrangis; Jorgen A Kurtzhals; Bamenla Q Goka
Journal:  Malar J       Date:  2012-12-17       Impact factor: 2.979

10.  Assessment of proarrhythmic activity of chloroquine in in vivo and ex vivo rabbit models.

Authors:  Shailaja B Khobragade; Pankaj Gupta; Prashant Gurav; Girish Chaudhari; Madhumanjiri M Gatne; Vyas M Shingatgeri
Journal:  J Pharmacol Pharmacother       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.